Luis A. Mariñas Pardo-rekin lankidetzan egindako argitalpenak (7)

2021

  1. Systemic treatment of immune-mediated keratoconjunctivitis sicca with allogeneic stem cells improves the schirmer tear test score in a canine spontaneous model of disease

    Journal of Clinical Medicine, Vol. 10, Núm. 24

2018

  1. Allogeneic adipose-derived mesenchymal stem cells (Horse Allo 20) for the treatment of osteoarthritis-associated lameness in horses: Characterization, safety, and efficacy of intra-articular treatment

    Stem Cells and Development, Vol. 27, Núm. 17, pp. 1147-1160

2014

  1. Dopamine mobilizes mesenchymal progenitor cells through d2-class receptors and their pi3k/akt pathway

    Stem Cells, Vol. 32, Núm. 9, pp. 2529-2538

  2. Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 69, Núm. 6, pp. 730-740

  3. Uso de células progenitoras mesenquimales alogénicas en patologías ortopédicas en caballos

    Equinus: Medicina y cirugía equina, Núm. 39, pp. 48-60

2012

  1. Enrichment of neural-related genes in human mesenchymal stem cells from neuroblastoma patients

    International Journal of Molecular Medicine, Vol. 30, Núm. 2, pp. 365-373

2011

  1. Mesenchymal niches of bone marrow in cancer

    Clinical and Translational Oncology, Vol. 13, Núm. 9, pp. 611-616